20 participating SITES (NH & SH)
in the 2021-2022 season
Central African Republic, Bangui
Institut Pasteur Bangui (IPB)
The Institut Pasteur of Bangui (IPB) is a recognized public utility establishment, subject to an agreement between the Institut Pasteur in Paris and the government of the Central African Republic. It was inaugurated on February 25, 1961. After more than fifty years in the service of biomedical research in Central Africa, the establishment now employs around one hundred people.
https://pasteur-bangui.org/ (in french)
Emmanuel NAKOUNE, Main Investigator
• Pediatric complex hospital of Bangui
• Boali secondary hospital
Institut Pasteur of Dakar (IPD)
The Institut Pasteur of Dakar Foundation (IPD) is a non-profit association of public utility, concerned with promoting public health and well-being in West Africa. Since its founding in 1896 by one of Louis PASTEUR's disciples, Émile Marchoux, the IPD has been at the forefront of the fight against infectious diseases. Since 2009, the Institut Pasteur de Dakar has been a Senegalese foundation, jointly managed by the government of Senegal and the Institut Pasteur (Paris).
https://www.pasteur.sn/en (in english)
Ndongo DIA, Main Investigator
• Hôpital Albert Royer Dakar, CHU FANN
• Hôpital Général Idrissa Pouye de Grand Yoff
• Hôpital d'enfants de Diamniadio (HED)
Ivory Coast, Abidjan
National Institute of Public Hygiene
The national institute is a public health institution whose mission is the control of infectious diseases. As such, it includes an epidemiological surveillance unit that conducts research on influenza.
http://www.inhp.ci/ (in french)
Daouda COULIBALY, Main Investigator
• University hospital of Treichville (Abidjan City, Abidjan autonomous district)
• University hospital of Bouaké (Bouaké City, Gbêkê Region)
• University hospital of Angre
• General hospital of Agnibilékro (Agnibilékro City, Indénié-Djuablin Region)
• Yopougon Attié Hospital (Yopougon City, Abidjan autonomous district)
• Regional Hospital of Korhogo
• Regional Hospital of San Pedro
• Regional Hospital of Man
Kenya Medical Research Institute (KEMRI) and US Centers for Disease Control and Prevention (CDC)
Kenya has conducted surveillance for influenza since 2006. Published data from these surveillance activities have shown a substantial burden of influenza, especially among children aged less than five years.
The GIHSN study is conducted using the existing health and demographic surveillance system (HDSS) in Western Kenya to estimate the incidence of influenza- and respiratory syncytial virus (RSV) - associated hospitalizations, and to quantify the distribution of the different influenza strains circulating in Kenya.
Data collected from this study will help bridge the gap on the burden of disease data in Kenya, particularly among the elderly as recently requested by the Kenya National Immunization Technical Advisory Group.
https://www.kemri.org/ (in english)
Dr Nancy A. OTIENO, Main Investigator
• Coast Provincial General Hospital (Mombasa City, Mombasa County)
• Nyeri Provincial General Hospital (Nyeri City, Nyeri County)
• Kenyatta National Hospital (Nairobi City, Nairobi County)
• Nakuru County Referral Hospital (Nakuru City, Nakuru County)
• Kakamega County Referral Hospital (Kakamega City, Kakamega County)
• Siaya County Referral Hospital (Siaya City, Siaya County)
• Marsabit County Referral Hospital (Marsabit City, Marsabit County)
Direction of Epidemiology and Disease Control - Ministry of Health Morocco
The National Influenza center is the national referral laboratory located at the National Institute of Hygiene in Rabat. It is WHO labelled and has a main collaboration with the US CDC.
In Morocco, the sentinel network for influenza virologic surveillance is located in 8 sentinel sites from both ambulatory and hospital sector. It is organization is established through ministry of health regulation.
Dr Imad CHERKAOUI, Main Investigator
South Africa, Johannesburg
Respiratory and Meningeal Pathogens Research Unit
RMPRU is a research Unit focused on the epidemiology, transmission, prevention and diagnosis of vaccine preventable diseases. RMPRU forms part of and is administered by the Wits Health Consortium, a wholly owned subsidiary of the University of the Witwatersrand.
RMPRU was established in 1997, with an original research mandate to investigate pneumococcal diseases at the molecular, epidemiological, clinical and pharmacological levels. Over time, the Unit has evolved to include investigating the clinical and molecular epidemiology of other bacteria and respiratory viruses that are associated with pneumonia and meningitis. Also, the Unit has established itself to be a premier clinical trial facility for vaccine and training platforms for post-graduate students.
The Unit has undertaken pivotal studies on pneumococcal conjugate vaccine, which have helped inform the utilisation of these vaccines in low-to-middle income countries. Also, the pneumococcal vaccine studies have helped inform the interaction of pneumococcus in relation to respiratory viruses and tuberculosis associated acute community acquired pneumonia. More recently, the Unit has further evolved to focus specifically on the epidemiology and prevention of infections during the neonatal period, including programs aimed at vaccinating pregnant women to confer passive immunity and protect infants during their first few months of life. These include studies on the influenza vaccines, GBS conjugate vaccine, pertussis vaccine and RSV vaccines.
Marta NUNES, Main Investigator
• Chris Hani Baragwanath Academic Hospital (Johannesburg City)
• Bheki Mlangeni District Hospital (Johannesburg City)
Argentina, Buenos Aires
The National Reference Laboratory for Influenza and other respiratory viruses
From 2017-2018 to 2018-2019
Since 1996 the National Reference Laboratory/WHO National Influenza Centre (NIC) of Argentina serves as a central repository for acute respiratory illness surveillance data.
The central hospital of the study is a health institution, where activities of prevention, treatment, diagnosis and rehabilitation are conducted, as well as teaching and research activities.
The identification of influenza and other respiratory viruses is conducted at the Respiratory Virus Laboratory, Virology Department, including the influenza subtyping, determination of the influenza B lineages and influenza A and B genomic characterization according to the protocol of a real time platform validated by the US Center for Disease Control and Prevention (CDC).
• Pr Elsa BAUMEISTER, Main Investigator & Project Director
• Pr Graciela CABRAL, Co-Investigator & Project Coordinator
National Hospital "Prof Alejandro Posadas" (Villa Sarmiento City, Buenos Aires Province)
Hospital Pequeno Principe
Pequeno Principe Hospital is a philanthropic institution, being a reference in pediatrics in the country.
It has performed influenza hospital-based surveillance since 2010, being a sentinel reference to cases of severe acute respiratory infection (SARI) for pediatric patients from Curitiba and other metropolitan region municipalities.
The hospital has a Department of Epidemiology and Infection Control that performs this surveillance. This department has participated in the GIHSN project - 2018- 2019 season and 2019-2020.
http://pequenoprincipe.org.br/ (in english and portuguese)
• Pr Sonia M. RABONI, Main Investigator
• Heloisa I. G. GIAMBERARDINO, Co-Investigator
Hospital Pequeno Principe (Curitiba City, Paraná State)
United States of America, New York City
Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes eight hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.
https://icahn.mssm.edu/ (in english)
Dr. Viviana SIMON, Main Investigator
• The Mount Sinai Hospital
• Mount Sinai Beth Israel
• Mount Sinai Queens
• Mount Sinai Brooklyn
• Mount Sinai West
• Mount Sinai Morningside
• Mound Sinai South Nassau
• New York Eye and Ear Infirmary of Mount Sinai
Canadian Center for Vaccinology
The Canadian Center for Vaccinology (CCfV) is a multidisciplinary vaccinology research centre of Dalhousie University developed with funding from the Canada Foundation for Innovation, which brings together investigators from adult and pediatric infectious diseases, internal medicine, geriatrics, health law and bioethics, public health, nursing, pharmacy, epidemiology, health outcomes and health economics. CCfV is the lead institution and coordinating center for the Canadian Immunization Research Network. The SOS Network is coordinated by the Canadian Center for Vaccinology in Halifax, Nova Scotia.
https://centerforvaccinology.ca/ (in english)
• Dr Shelly A. McNEIL, Main Investigator
• Dr Melissa K. ANDREW, Co-Investigator
Mexico, Mexico City
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
The Ministry of Health Coordination Center of the National Institutes of Health and High Speciality Hospital (CCINSHAE)'s mission is to promote the highest level of scientific knowledge and to develop, maintain, and renew scientific human and physical resources that will ensure the Nation's capability to prevent disease, enhance health and reduce illness and disability.
The Mexico National Institutes of Health and High Specialty Hospitals Surveillance Network integrate 12 National Health Institutions and Hospitals to ensure a wide geographic representation of the north, central and south areas of the country. Its purpose is the timely identification and estimation of the incidence of severe illness (hospitalization) and the description of the clinical characteristics caused by influenza and other respiratory viruses, as well as new and emerging infectious treats to ultimately protect and improve the health of the individual and the allocation of economic resources.
https://www.incmnsz.mx/opencms/ (in spanish)
• Dr Guillermo M. RUIZ-PALACIOS, Main Investigator
• María de LOURDES GUERRERO, Co-Investigator
• Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán (Mexico City)
• Instituto Nacional de Enfermedades Respiratorias (Mexico City)
• Instituto Nacional de pediatría (Mexico City)
• Hospital Infantil de México (Mexico City)
• Hospital General Dr. Manuel Gea González (Mexico City)
• Hospital Central Dr. Ignacio Morones Prieto (San Luis Potosí City, San Luis Potosí State)
Tropical Medicine Institute Daniel A. Carrion, San Marcos University, Lima – Peru and Centro de Investigaciones Tecnológicas, Biomédica y Medioambientales
The Tropical Medicine Institute Daniel Carrion´s mision is to promote a highest level of scientific knolewdge in Tropical Infectious Diseases to contribute in the health care of the peruvian population. This Tropical Institute (IMT DAC in Spanish)works closely with the CITBM under a collaborative agreementincluding associate business and international research activities.
CITBM is the first Center of Excellence in Peru dedicated to the integration of science, development and technological innovation. CITBM is collaborating in multiple national and multinational biomedical, technology and innovation projects, including the development of rapid diagnostic tests and vaccines for infectious tropical diseases as malaria, leptospirosis, leishmaniasis and meningeal tuberculosis. Additionally, it leads the international consortium MDRTBNet (aERANet Lac initiative), with reference institutes of tuberculosis in Germany, Spain, France, Brazil and Italy.
http://citbm.unmsm.edu.pe/ (in spanish)
Dr Víctor A. LAGUNA TORRES, Main Investigator
• Hospital Nacional 2 de Mayo (Lima City, Lima Province)
• Clínica Internacional (Lima City, Lima Province)
• Hospital de Apoyo II Santa Rosa (Piura City, Piura Province)
Institute of Epidemiology, Disease Control and Research
Institute of Epidemiology Disease Control And Research was is responsible developing public health plans for the government of Bangladesh to implement.
The present Institute of Epidemiology, Disease Control and Research (IEDCR) was established in 1976 by the government of Bangladesh which called for the establishment of an institute for epidemiological and communicable disease research as well as functioning of disease control programs mainly in the form of parasitic and entomological containment of vector borne diseases through application of epidemiological principles.
http://www.iedcr.org/ (in english)
Dr Meerjady S. FLORA, Main Investigator
The study team is composed by the School of Public Health, Fudan University (SPH), Soochow University Affiliated Children’s Hospital (SCH) and Suzhou Center for Disease Control and Prevention (CDC).
All three institutions are well coordinated since foundation by US CDC in March 2011.
Fudan University is a comprehensive research university in China. As one of the first participants in the 211 and 985 projects. Fudan has 28 schools and 11 affiliated hospitals.
Since Mar 2011, founded by US CDC, the influenza surveillance system was established in Soochow University Affiliated Children’s Hospital (SCH). The surveillance includes influenza-like illness (ILI) and severe acute respiratory infection (SARI) patients.
SCH is a comprehensive tertiary hospital for children, one of the national influenza monitoring network hospitals, integrated with medical treatment, teaching, research and preventive health care.
http://shmc.fudan.edu.cn/eng (in english and chinese)
Dr Tao ZHANG, Main Investigator & Coordinator
Children’s Hospital of Soochow University (Soochow City, Jiangsu Province)
Wuhan Institute of Virology, Chinese Academy of Sciences
The Wuhan Institute of Virology, Chinese Academy of Sciences is a research institute on virology administered by the Chinese Academy of Sciences (CAS), which reports to the State Council of the People’s Republic of China.
The strategic positioning of Wuhan Institute of Virology is to face the national population health, sustainable development of agriculture and national security, look on the international frontier for the research field of virology, focusing on the researches on newly emerging, outburst infectious diseases and biosecurity, major viral infectious diseases etiology and innovative drug for agriculture, environmental microbes and ecological protection, virus bionic and emerging biotechnology, virus identification, system classification and bioinformatics and other aspects, in the construction of high-level biosafety research and technology system, biological nano-devices, green agricultural technology Integration and application and other scientific frontiers, it is to make the original innovation contribution, enhance our emergency responsiveness to new and sudden infectious diseases, built the Wuhan Institute of Virology into a comprehensive virology research institution with international advanced level.
http://institute.wuhanvirology.org/ (in english and chinese)
Pr Jianjun CHEN, Main Investigator
Indian Council of Medical Research - National Institute of Virology
The National Institute of Virology is one of the major Institutes of the Indian Council of Medical Research (ICMR). It was established at Pune, Maharashtra State in 1952 as Virus Research Centre (VRC) under the auspices of the ICMR and the Rockefeller Foundation (RF), USA. It was an outcome of the global program of the RF for investigating the Arthropod Borne viruses. Since the studies on arboviruses and their arthropod vectors involve most of the basic principles and techniques of general virology, entomology and zoology, these viruses were also considered to be an ideal group, to begin with, for intensive training and research in virology in our country. The RF withdrew its support in 1967 and since then the Institute is entirely funded by the ICMR.
https://www.niv.co.in/ (in english)
Varsha POTDAR, Main Investigator
• Jehangir hospital
• KEM hospital, Pune
• In-laks bhudrani
• BJ medical college and sasson hospital
Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Department of Internal and Pulmonary Medicine
The SKIMS is engaged to provide high quality patient care, academic courses and need-based biomedical research to provide better patient care.
The institute has been one of the sites of the CDC,USA sponsored Multisite Surveillance for Influenza across India that has documented the patterns of influenza circulation in India.
http://skimsmc.edu.in/ (in english)
Dr Parvaiz KOUL, Main Investigator
Sher-i-Kashmir Institute of Medical Sciences SKIMS (Srinagar City, Jammu & Cashmir Territory)
Patan Academy of Health Sciences
Patan Academy of Health Sciences (PAHS) is a non-profit, public, health science university established with an act of parliament in 2008. The central rationale for the establishment of PAHS was to contribute to the reduction of disparity in the health status among rural, urban, and disadvantaged populations in Nepal.
The site is a collaborating Oxford vaccine research group and implementing influenza surveillance project supported by US Centers for Disease Control and Prevention since 2009.
Until 2009, influenza-related surveillance work were patchy and has not had systematic effort. To systematize and strengthen influenza surveillance activities, PAHS participated in CDC influenza call and received a grant in 2009.
After the establishment of Nepal National Influenza Center in 2010, national health system started testing influenza sample within the country. Since then, Patan Academy started Influenza surveillance as one of the sentinel sites in Nepal under NIC.
Since 2011 Patan hospital sentinel sites have been collecting ILI epidemiological data and sample regularly on weekly basis.
https://www.pahs.edu.np/ (in english)
Kedar P. BARAL, Main Investigator
• Manmohan Memorial Community Hospital (Kathmandu City, Kathmandu district)
• Hetauda Hospital (Hetauda City, Makwanpur district)
Edouard Herriot Hospital, Department of Hygiene, Epidemiology and Prevention
From 2017-2018 to 2019-2020
Surveillance of nosocomial influenza was set-up in Edouard Herriot hospital in 2004 to estimate the risk of hospital acquired-ILI for hospitalized patients in short-stay units, and to identify determinants associated with nosocomial Influenza infection. Determinants from the community (influenza incidence, vaccine coverage, etc.) and from the hospital (underlying diseases, two-bed rooms, vaccine coverage among HCW, etc.) are explored to describe and initiate preventive measures to avoid hospital outbreak of influenza.
Since 2012 the hospital is involved into the FluVac study. This is a case-control prospective study coordinated by the REIVAC (Réseau national d’investigation clinique en vaccinologie). The main objective of this study is to assess the effectiveness of influenza vaccine in hospitalized patients with laboratory-confirmed influenza.
Pr Philippe VANHEMS, Main Investigator
Edouard Herriot Hospital (Lyon City)
I-REIVAC network - Inserm
5 universitary hospitals, all members of I-REIVAC network, are involved in the project in 2019-2020.
The I-REIVAC coordination team manage the monitoring of data in connecting with the local teams of each site to correct the errors, incoherencies or missing values within the database.
https://www.inserm.fr/ (in french and english)
• Pr Odile LAUNAY, Main Investigator
• Dr Can L. LUONG, Co-Investigator
• Zineb LESIEUR, Co-Investigator
• Hôpital Cochin (Paris City)
• Hôpital Bichat (Paris City)
• Hospices Civils de Lyon (Lyon City)
• Centre Hospitalier Universitaire de Montpellier (Montpellier City)
• Centre Hospitalier Universitaire de Rennes (Rennes City)
The National Institute for Infectious Diseases "Prof. Dr. Matei Bals"
The National Institute for Infectious Diseases “Prof. Dr. Matei Bals” is the excellence center in Romania for prevention, management and research in area of infectious diseases. As a research center, the hospital has extensive experience in conducting clinical trials in the field of infectious diseases having a dedicated and accredited (FDA) clinical trials center. Vaccine trials were routinely conducted in National Institute of Infectious Diseases “Prof. Dr. Matei Bals” Bucharest (flu, pneumococcal)Severe influenza cases, both in adult and pediatric population are managed in the Institute.
The Institute is also part in the national influenza surveillance system (Romania has a national sentinel type surveillance system for influenza).A dedicated hospital epidemiology unit contributes to the national influenza surveillance program.
Anca DRAGANESCU, Main Investigator
National Institute for Infectious Diseases "Prof. Dr. Matei Bals" (Bucharest City, Bucharest Municipality)
FSBI National Center of Epidemiology and Microbiology by N.F.Gamaleya
D.I. Ivanovsky Institute of Virology is one of the first-rate research organizations in the field of ecology, epidemiology, molecular biology, and molecular virology. Its mission is fundamental researching of virology, development and improvement of diagnostic methods and assessment of new antivirals against highly infectious and social diseases. Institute has been involved in influenza surveillance since 1959 both in Russia (USSR) and WHO. Since 2014 Institute had became a part of FSBI “N.F. Gamaleya FRCEM”.
https://gamaleya.org/en/ (in english and russian)
Elena BURTSEVA, Main Investigator
Clinical Hospital for Infectious Diseases n°1 (Moscow City, Central Federal District)
Smorodintsev Research Institute of Influenza
RII is a leading institution in the field of influenza and ARI surveillance in Russia.
RII incorporates Federal Influenza and ARI Centre and WHO National Influenza Centre, successfully operating both on the national and global levels as an integral part of WHO global influenza surveillance and response system.
https://www.influenza.spb.ru/en/ (in english and russian)
Anna SOMININA, Main Investigator
• Clinical Infectious Diseases Hospital (St-Petersburg City, Northwestern Federal District)
• Children's Infectious Multidisciplinary Hospital #5 (St-Petersburg City, Northwestern Federal District)
• Children's Multidisciplinary Hospital #4 (St-Petersburg City, Northwestern Federal District)
Serbia, Novi Sad
Institute of Public Health of Vojvodina
From 2017-2018 to 2019-2020
The Institute of public health (IPH) of Vojvodina have significant scientific and practical experience in the field of influenza and immunization that has been acquired in numerous studies. The IPH of Vojvodina is the leading state Institution for the communicable diseases surveillance (including influenza) that are envisaged for compulsory reporting in Vojvodina.
The World Health Organization (WHO) as the National Influenza Centre (NIC) has recognized the IPH of Vojvodina, Centre of virology, since 1953. NIC is part of the WHO Global Influenza Surveillance Network, with the principal task of continuous virologic surveillance of influenza virus activity in population of Vojvodina.
http://www.izjzv.org.rs/ (in serbian and english)
• Dr Snežana MEDIC, Main Investigator & Project Coordinator
• Dr Mioljub RISTIC, Co-Investigator & Province Coordinator
• Institute of Pulmonary Diseases of Vojvodina (Sremska Kamenica City, Autonomous Province of Vojvodina)
• Clinical Center of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)
• Institute for Health Care of Children and Youth of Vojvodina (Novi Sad City, Autonomous Province of Vojvodina)
The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, is a non-profit scientific and healthcare entity, whose primary purpose is to encourage, to promote and to develop scientific and technical health and biomedical research in Valencia Region.
FISABIO integrates and manages the Health Research Map of the Centre for Public Health Research, Dr. Peset University Hospital Foundation, Alicante University General Hospital Foundation, Elche University General Hospital Foundation, and the Mediterranean Ophthalmological Foundation. In addition, FISABIO assumes the scientific activity of other 18 Health Departments.
http://fisabio.san.gva.es/ (in english, spanish and catalan)
Javier GARCIA RUBIO, Main Investigator
• Hospital General de Castellón (Castelló de la Plana City)
• Hospital La Fe de Valencia (Valencia City)
• Hospital Dr. Peset de Valencia (Valencia City)
• Hospital General de Alicante (Alicante City)
L.V.Gromashevsky Institute of Epidemiology & Infectious Diseases NAMS of Ukraine
Since 2005 the Institute of Epidemiology and Infectious Diseases has regularly (twice a year) submitted influenza virus isolates to the WHO Collaborating Centers in Atlanta and London.
Since 2007 was established sentinel site virologic and epidemiologic surveillance for influenza-like illness (ILI) and severe acute respiratory infection (SARI) from influenza. In 2008 was developed an electronic web-based data collection and analysis program at www.ukrinfluenza.com.ua to support the sentinel surveillance system. There are collected casebase SARI data on weekly manner from 10 hospitals, which are accessed for authorized persons. Above mentioned site collected data in electronic form (SARI patient registration record-book).
These data can be transmitted with virological information, but without personal data to another site if so. The information bulletin on epidemiological and virology aspects of influenza on a base of ILI and SARI sentinel surveillance data is issued on English and Ukrainian every week.
Alla MIRONENKO, Main Investigator
American University of Beirut Medical Center
Infectious diseases remain among the leading causes of morbidity and mortality in the Middle East, with diseases such as pneumonia, gastroenteritis, malaria, and tuberculosis presenting a major burden in our region.
The Center for Infectious Diseases Research (CIDR) at the American University of Beirut Medical Center (AUBMC) promotes research in basic, translational, and clinical aspects of infectious diseases.
The aim of the CIDR laboratory is to function as a national and regional reference laboratory with emphasis on the diagnosis of endemic and epidemic infectious diseases relevant to our region.
https://www.aubmc.org.lb/pages/home.aspx (in english)
Dr Ghassan DBAIBO, Main Investigator
• Bekaa Hospital (Taalabaya City, Bekaa region, Zahleh district)
• Keserwan Medical Center KMC (Jounieh City, Mount Lebanon region, Keserwan district)
• Rafik Hariri University Hospital (Beirut City)
• Makassed General Hospital (Beirut City)
• American University of Beirut Medical Center (Beirut City)
• New Mazloum Hospital (Tripoli City, North Lebanon region, Tripoli district)
Turkish Society of Internal Medicine
Turkish Society of Internal Medicine (TSIM) was founded in 1995 as a non-profit organization and since then the Society has grown fast and reached over 1300 members currently.
The Society has a mission to be leader in the training and continuing medical education of internal medicine specialists and subspecialists; and in the delivery of high-quality patient care.
Aligned with this mission, one of the goals of the Society is to support scientific research projects in the field of internal medicine and to mediate a respectful relationship between the Society and the public, the academia and the industry.
http://www.tihud.org.tr/ (in turkish)
• Dr Serhat UNAL, Main Investigator
• Dr Mine DURUSU TANRIOVER, Co-Investigator and Site Coordinator
• Dr Lale OZISIK, Investigator
• Dr Erdal INCE, Investigator
• Pr Ergin ÇIFTÇ, Investigator
• Pr Halil OZDEMIR, Investigator
• Pr Fatma SEBNEM ERDINC